We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

13 hedge funds and large institutions have $3.27M invested in ALPS Medical Breakthroughs ETF in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

550% more funds holding

Funds holding: 213 (+11)

132% more capital invested

Capital invested by funds: $1.41M → $3.27M (+$1.86M)

6.63% more ownership

Funds ownership: 0%6.63% (+6.6%)

Holders
13
Holders Change
+11
Holders Change %
+550%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

SBIO Hedge Fund Activity: Q1 2015 in Review

13 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2015, worth a combined $3.27M — up 132% from $1.41M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SBIO positions and 1 closed out — a net gain of 11 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $1.19M. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $1.4M sold.

  • 13 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2015, up from 2 in Q4 2014.
  • Funds reported $3.27M of ALPS Medical Breakthroughs ETF stock for Q1 2015, up 132% quarter-over-quarter.
  • 12 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2015 and 1 closed out, a net change of +11 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2015 was Jane Street, an estimated $1.19M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2015 was Virtu KCG Holdings, an estimated $1.4M sold.

Based on aggregated 13F filings for Q1 2015.